Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naïve chronic hepatitis B: A case report and review of the literature

Tenofovir disoproxil fumarate (TDF) is a potent nucleotide analogue that is recommended as first-line therapy for patients with chronic hepatitis B. The results of a longitudinal study of TDF treatment demonstrated no development of resistance. We observed one treatment-naïve chronic hepatitis B (CH...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Woo Hee, Lee, Hyun Jae, Bang, Ki Bae, Kim, Seok Bae, Song, Il Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937209/
https://www.ncbi.nlm.nih.gov/pubmed/29740207
http://dx.doi.org/10.3748/wjg.v24.i17.1919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937209/
https://www.ncbi.nlm.nih.gov/pubmed/29740207
http://dx.doi.org/10.3748/wjg.v24.i17.1919

Ejemplares similares